Matt Stella Team Janssen Oncology

As the new National Policy & Advocacy Director in Oncology at Janssen Matthew’s is an avid cyclist. When he learned about Janssen’s commitment to Road to Victories he signed up almost immediately. His work and passion for cycling make him a great team member. This will be a great introduction to the MMRF and most importantly, he will have the chance to spend a week with multiple myeloma patients and their caregivers. He looks forward to the connections and relationships that will form.

I’m riding for all those impacted by myeloma. But especially one.
Matt Stella
Being a part of the Road to Victories Team holds a very special place for me. I lost one of my best friends in 2015 to multiple myeloma.
Read More
09/12/2019
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More